Skip to main content
GKOS
NYSE Life Sciences

Glaukos Q2 Sales Surge 50%, Guidance Raised to $700M on iDose TR and Epioxa Momentum

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$173
Mkt Cap
$9.495B
52W Low
$73.16
52W High
$166
52W Position info
136% above low
Off High info
at 52W high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

GKOS has more than doubled off its 52-week low of $73.16 on elevated volume (2.9× avg).

Summary

Glaukos delivered a standout Q2 with net sales of $185.6M, up 50% YoY, driven by 64% growth in U.S. glaucoma sales. Gross margins expanded to 82% GAAP and 85% non-GAAP, reflecting operating leverage. Management raised full-year 2026 revenue guidance to $680M-$700M, a significant jump from the prior $620M-$635M range, signaling confidence in the iDose TR and Epioxa launches. The company remains unprofitable but narrowed its non-GAAP net loss to $8.3M ($0.14/share) from $13.6M a year ago. With $289M in cash and no debt, the balance sheet supports continued investment in its pipeline. The stock is trading near a 52-week high, and this beat-and-raise quarter reinforces the growth narrative.

At the time of this announcement, GKOS was trading at $173.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $73.16 to $166.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

GKOS - Latest Insights

GKOS
Oct 28, 2026, 5:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $215.00
Real-time Price: $247.00 info
Change: +$32.00 (+15%) info
Market Cap: $14.631B info
GKOS
Oct 28, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $196.05
Real-time Price: $247.00 info
Change: +$50.95 (+26%) info
Market Cap: $14.631B info
GKOS
Oct 28, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $181.43
Real-time Price: $247.00 info
Change: +$65.57 (+36%) info
Market Cap: $14.631B info
GKOS
Oct 09, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $161.29
Real-time Price: $247.00 info
Change: +$85.71 (+53%) info
Market Cap: $14.631B info
GKOS
Oct 08, 2026, 11:09 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $153.16
Real-time Price: $247.00 info
Change: +$93.85 (+61%) info
Market Cap: $14.631B info